Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Genethon

Yposkesi Acquisition Fuels SK's Global Push Into Biologics Manufacturing

South Korean conglomerate SK Group continues its cross-border acquisitions of contract manufacturers, this time of French biologics specialist Yposkesi, marking a new push into the gene and cell therapy sector as it looks to become a global leader in the production of both innovative chemical drugs and biologics.

Deals Manufacturing

Audentes Set To Resume XLMTM Trial As US Hold Lifts

Trial of high-need gene therapy set to restart following the deaths of several participants and the lifting of a clinical hold imposed by the US FDA last year.

Gene Therapy Clinical Trials

Audentes' Gene Therapy Allows Ventilator Independence For Rare Disease

Audentes Therapeutics is aiming for regulatory submissions next year for its lead product, a skeletal muscle-targeted gene therapy, which continues to show promise in X-linked myotubular myopathy.

Rare Diseases Gene Therapy

Durability Seen With Novartis, Roche SMA Therapies Heading For Market

Novartis and Roche have announced additional interim clinical data as their candidate spinal muscular atrophy therapies near the marketplace.

Gene Therapy Neurology
See All

Company Information

  • Industry
  • Academic and Research Institutions
  • Other Names / Subsidiaries
    • Généthon
UsernamePublicRestriction

Register